NASDAQ:MREO

Mereo Biopharma Group Stock Predictions

etoro logo Buy MREO
*Your capital is at risk
$0.334
-0.0052 (-1.53%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

MREO Prediction Chart

MREO Predictions History

Latest community submissions for MREO.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 27, 2025 $2.84 +1.36% $2.66 X 93.30% 0
Jun 27, 2025 Bullish $2.66 X 0
Jun 17, 2024 $4.18 -1.61% $4.25 X 98.39% 0
Jun 17, 2024 Bullish $4.25 X 0
JS JS Pro
Jan 16, 2024 $2.98 +1.02% $3.09 V 96.44% 1
Jan 16, 2024 $2.88 -2.45% $3.09 X 93.13% 0
Jan 16, 2024 $2.90 -1.53% $3.09 X 94.01% 0
Dec 29, 2023 $2.27 -2.47% $2.31 V 98.37% 1
Dec 29, 2023 $2.29 -1.54% $2.31 V 99.31% 4
Dec 29, 2023 Bullish $2.31 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MREO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT MEREO BIOPHARMA GROUP PLC
Mereo Biopharma Group
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE